Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 35-39.doi: 10.3736/jcim20100107

• Original Clinical Research • Previous Articles     Next Articles

Efficacy of Shenshi Qianghuo Dihuang Decoction in rheumatoid arthritis: A randomized controlled trial

 Zhao-wei Chen, Jian Sun, Yu-mei Li, Yong-qiang Chen   

  1. Department of Orthopaedics and Traumatology, Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai 200071, China
  • Received:2009-07-27 Accepted:2009-10-15 Online:2010-01-20 Published:2010-01-15
  • Contact: Yong-qiang Chen E-mail:chenyongqiang@medmail.com.cn

Background

In China, patients with rheumatoid arthritis (RA) are often treated with traditional Chinese herbal medicine. There are certain advantages of traditional Chinese medicine therapy in treatment of RA.
Objective

To assess the efficacy and adverse reaction of Shenshi Qianghuo Dihuang Decoction (SQDD), a compound traditional Chinese herbal medicine, in treatment of RA.
Design, setting, participants and interventions

This was a 24-week prospective, randomized, controlled trial. Ninety RA patients meeting inclusion criteria from Shanghai Municipal Hospital of Traditional Chinese Medicine were randomly assigned to receive SQDD or methotrexate (MTX) with 45 cases in each group. The patients in SQDD group were orally administered with SQDD twice daily, and the patients in MTX control group were treated by oral administration of 15 mg MTX once a week. All the RA patients were treated for 24 weeks.
Main outcome measures

The primary outcome was the number of patients achieving the American College of Rheumatology 20% response. Clinical and laboratory parameters including tender joint count and swollen joint count, patient’s global assessment and physician’s global assessment (using a 0– 10 cm visual analogue scale), duration of morning stiffness, plasma C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR) and value of anti-cyclic citrullinated peptide (CCP) antibody were assessed.
Results

After 24-week treatment, the response rates in SQDD group and MTX group were 62.53% (24/41) and 67.5% (28/40) respectively, and there was no statistical difference between the two groups (P>0.05). The patient’s global assessment and physician’s global assessment, morning stiffness, grip strength, tender joint count, swollen joint count and the levels of ESR, CRP and anti-CCP antibody in SQDD and MTX groups were improved significantly as compared with those before treatment, and there were no significant differences between the two groups. The efficacy of MTX in improving rest pain and joint tenderness was better than that of SQDD (P<0.05). The incidence rate of adverse reactions in SQDD group was 9.75% (4/41), significantly lower than 32.5% (13/40) in MTX group (P<0.05).
Conclusion

SQDD has a therapeutic effect on RA, and the adverse reactions are less than MTX.

Key words: Rheumatoid arthritis, Shenshi Qianghuo Dihuang Decoction, Methotrexate, Randomized controlled trial

Table 1

The general data of two groups"

Characteristics MTX group (n=40) SQDD group (n=41)
Cases (Male/Female) 21/19 22/19
Mean age ($\bar{x}s$, years) 46.23±12.21 45.76±10.21
Duration of illness (?$\bar{x}s$, months) 52.21±41.31 47.32±48.32
Function of joint (Ⅰ/Ⅱ/Ⅲ/Ⅳ) 0/29/10/1 0/31/10/0
X-ray stage (Ⅰ/Ⅱ/Ⅲ/Ⅳ) 16/20/4/0 11/25/5/0

Figure 1

Flow diagram of this randomized trial"

Table 2

Changes of clinical parameters before and after treatment in two groups ($\bar{x}s$)"

Variable Baseline Twelve-week treatment Twenty-four-week treatment
MTX group
(n=40)
SQDD group
(n=41)
MTX group
(n=40)
SQDD group
(n=41)
MTX group
(n=40)
SQDD group
(n=41)
Pain (VAS 0 – 10) 6.61±1.31 6.92±1.22 4.32±0.21** 5.91±0.51** 3.13±1.23** 5.51±1.53**
Morning stiffness (min) 120.12±13.11 115.21±11.32 59.22±11.31* 65.36±14.22* 45.78±10.31** 46.32±14.52**
Grip strength (kPa) 12.32±9.21 12.25±3.11 14.45±4.12* 14.32±3.24* 15.67±4.22* 15.54±3.14*
Tender joint count 10.51±0.81 11.23±0.54 7.33±2.67* 8.93±1.35* 6.22±0.67* 7.51±1.15*
Swollen joint count 3.52±0.12 4.01±0.12 2.55±0.13** 2.95±0.23** 1.55±0.13** 1.72±0.32**
Patient's global assessment (VAS 0 – 10) 6.19±0.28 7.01±0.38 3.55±0.82* 3.92 ±0.38* 3.14±0.20* 3.44 ±0.18*
Physician's global assessment (VAS 0 – 10) 6.02±0.15 6.12±0.12 4.51±0.44* 4.74±0.27* 3.51±0.44* 3.14±0.76*

Table 3

Changes of laboratory parameters before and after treatment in two groups (?$\bar{x}s$)"

Variable Baseline Twelve-week treatment Twenty-four-week treatment
MTX group
(n=40)
SQDD group
(n=41)
MTX group
(n=40)
SQDD group
(n=41)
MTX group
(n=40)
SQDD group
(n=41)
ESR (mm/h) 82.21±15.01 84.55±13.03 70.66±17.01* 74.43±16.01* 14.32±7.11** 15.55±5.24**
CRP (mg/L) 10.21±1.84 11.33±0.82 8.21±1.82* 9.43±1.81* 6.22±1.21** 6.22±1.51**
RF (×103 U/L) 155.01±12.21 47.02±21.91 109.11±32.10* 98.02±29.97* 97.01±13.12* 99.12±10.13*
Anti-CCP Ab (RU/L) 0.23±0.56 0.25±0.45 0.22±0.46** 0.21±0.35** 0.21±0.35* 0.22±0.45*
[1] Shen PA. Contemporary immunology in traditional Chinese medicine[M]. Beijing: People’s Medical Publishing House, 2003: 316-318
沈丕安 . 现代中医免疫病学[M]. 北京: 人民卫生出版社, 2003: 316-318
[2] American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update[J]. Arthritis Rheum, 2002,46(2):328-346
doi: 10.1007/BF03278953
[3] Koh ET, Seow A, Pong LY, Koh WH, Chan L, Howe HS, Lim TH, Low CK . Cross cultural adaptation and validation of the Chinese Health Assessment Questionnaire for use in rheumatoid arthritis[J]. J Rheumatol, 1998,25(9):1705-1708
[4] Albert DA, Huang G, Dubrow G, Brensinger CM, Berlin JA, Williams HJ . Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20[J]. J Rheumatol, 2004,31(5):856-866
[5] Li YM . Professor Shen Pi’an’s experience in herbal administration to treat rheumatoid arthritis[J]. Shanghai Zhong Yi Yao Za Zhi, 2009,43(1):21-22
李玉梅 . 沈丕安治疗类风湿性关节炎用药经验[J]. 上海中医药杂志, 2009,43(1):21-22
[6] Shen PA. Pharmacology and clinical use of traditional Chinese herbal medicine[M]. Beijing: People’s Medical Publishing House, 2006: 101
沈丕安 . 中药药理与临床运用[M]. 北京: 人民卫生出版社, 2006: 101
[1] Chiung-Hui Huang, Mei-Ling Yeh, Fang-Pey Chen, Daphne Wu. Low-level laser acupuncture reduces postoperative pain and morphine consumption in older patients with total knee arthroplasty: A randomized placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(4): 321-328.
[2] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[3] Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta, Amarilysde Toledo Cesar, José Nelson Martins Diniz, Helen de Freitas Santos, Edson Zangiacomi Martinez. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 2022, 20(3): 221-229.
[4] Xin Wang, Wen-juan Song, Yi Ruan, Bing-chu Li, Can Lü, Nian Huang, Fan-fu Fang, Wei Gu. Core muscle functional strength training for reducing the risk of low-back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 145-152.
[5] Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326.
[6] Ju-Yeon Park, Young-Won Kwon, Sun-Ah Kim, Sun-Dong Park, Chang-Hyun Kim, Jin-Hee Kim, Ju-Hee Lee. Polyherbal formula SC-E3 inhibits rheumatoid arthritis activity in a mouse model of type-II collagen-induced arthritis. Journal of Integrative Medicine, 2021, 19(3): 265-273.
[7] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[8] Jie Wu, Shu-wei Duan, Hong-tao Yang, Yue-yi Deng, Wei Li, Ya-ni He, Zhao-hui Ni, Yong-li Zhan, Shan Lin, Zhi-yong Guo, Jun Zhu, Jing-ai Fang, Xu-sheng Liu, Li-hua Wang, Rong Wang, Nian-song Wang, Xiao-hong Cheng, Li-qun He, Ping Luo, Shi-ren Sun s, Ji-feng Sun, Ai-ping Yin, Geng-ru Jiang, Hong-yu Chen, Wen-hu Liu, Hong-li Lin, Meng Liang, Lu Ma, Ming Chen, Li-qun Song, Jian Chen, Qing Zhu, Chang-ying Xing, Yun Li, Ji-ning Gao, Rong-shan Li, Ying Li, Hao Zhang, Ying Lu, Qiao-ling Zhou, Jun-zhou Fu, Qiang He, Guang-yan Cai, Xiang-mei Chen. Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2021, 19(2): 111-119.
[9] Xian Wang, Xuan Yin, Xiu-tian Guo, Yan Wang, Wen-qi Jin, Ai-jun Mao, Lixing Lao, Zhang-jin Zhang, Jie Zhang, Shi-fen Xu. Effects of the pestle needle therapy, a type of acupoint stimulation, on post-hemorrhoidectomy pain: A randomized controlled trial. Journal of Integrative Medicine, 2020, 18(6): 492-498.
[10] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[11] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[12] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[13] Pádraic J.Dunne, Julie Lynch, Lucia Prihodova, Caoimhe O'Leary, Atiyeh Ghoreyshi, Sharee A. Basdeo, Donal J.Cox, Rachel Breen, Ali Sheikhi, Áine Carroll, Cathal Walsh, Geraldine McMahon, Barry White. Burnout in the emergency department: Randomized controlled trial of an attention-based training program. Journal of Integrative Medicine, 2019, 17(3): 173-180.
[14] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[15] J.M. Oliver-Baxter, H.S. Whitford, D.A. Turnbull, M.J. Bond. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(5): 322-328.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022